Evidence map›Paper›PMID 26056434›Full record

ReviewDrug design, development and therapy2015

Antitumor effects of traditional Chinese medicine targeting the cellular apoptotic pathway.

Huanli Xu, Xin Zhao, Xiaohui Liu, Pingxiang Xu, Keming Zhang, Xiukun Lin

Abstract readReview
In one paragraph

Review in Drug design, development and therapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. The effect ofArchives of medical science : AMS · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Frontiers in pharmacology · 2025
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Targeting Reactive Oxygen Species in Cancer via Chinese Herbal Medicine.Oxidative medicine and cellular longevity · 2019
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Huanli XuDepartment of Pharmacology, School of Basic Medical Sciences, Capital Medical University, Beijing, People's Republic of China.
Xin ZhaoDepartment of Hepatobiliary Surgery, 302 Hospital of Chinese People's Liberation Army, Beijing, People's Republic of China.
Xiaohui LiuDepartment of Pharmacology, School of Basic Medical Sciences, Capital Medical University, Beijing, People's Republic of China.
Pingxiang XuDepartment of Pharmacology, School of Basic Medical Sciences, Capital Medical University, Beijing, People's Republic of China.
Keming ZhangDepartment of Hepatobiliary Surgery, 302 Hospital of Chinese People's Liberation Army, Beijing, People's Republic of China.
Xiukun LinDepartment of Pharmacology, School of Basic Medical Sciences, Capital Medical University, Beijing, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Defects in apoptosis are common phenomena in many types of cancer and are also a critical step in tumorigenesis. Targeting the apoptotic pathway has been considered an intriguing strategy for cancer therapy. Traditional Chinese medicine (TCM) has been used in the People's Republic of China for thousands of years, and many of the medicines have been confirmed to be effective in the treatment of a number of tumors. With increasing cancer rates worldwide, the antitumor effects of TCMs have attracted more and more attention globally. Many of the TCMs have been shown to have antitumor activity through multiple targets, and apoptosis pathway-related targets have been extensively studied and defined to be promising. This review focuses on several antitumor TCMs, especially those with clinical efficacy, based on their effects on the apoptotic signaling pathway. The problems with and prospects of development of TCMs as anticancer agents are also presented.

Indexed as

Antineoplastic Agents, PhytogenicApoptosisDrugs, Chinese HerbalHumansMedicine, Chinese TraditionalNeoplasmsAntineoplastic Agents, PhytogenicDrugs, Chinese Herbalantitumor effectsapoptotic pathwaytraditional Chinese medicine

Identifiers

PMID26056434
PMCPMC4445699

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.